In Vitro Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus , Including Heterogeneously Glycopeptide-Resistant Strains-Reference-Cited by-同舟云学术

In Vitro Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus , Including Heterogeneously Glycopeptide-Resistant Strains

Published:2006-09 Issue:9 Volume:50 Page:3189-3191
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Diederen Bram M. W.¹,van Duijn Inge²,Willemse Piet²,Kluytmans Jan A. J. W.²

Affiliation:

1. Laboratory of Medical Microbiology, St. Elisabeth Hospital, Tilburg, The Netherlands

2. Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands

Abstract

ABSTRACT The purpose of the present study was to assess the in vitro activity of daptomycin against a well-defined collection of methicillin-resistant Staphylococcus aureus (MRSA) isolates ( n = 98), including heterogeneously glycopeptide-resistant MRSA (hGISA) strains. Susceptibility testing was performed by using the Etest system. Daptomycin was potent against both glycopeptide-susceptible and hGISA strains.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00526-06

Reference21 articles.

1. Archer, G. L. 1998. Staphylococcus aureus: a well-armed pathogen. Clin. Infect. Dis.26:1179-1181.

2. In Vitro Activities of Daptomycin against 2,789 Clinical Isolates from 11 North American Medical Centers

3. Carpenter, C. F., and H. F. Chambers. 2004. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin. Infect. Dis.38:994-1000.

4. Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance Gene

5. Cosgrove, S. E., Y. Qi, K. S. Kaye, S. Harbath, A. W. Karchmer, and Y. Carmeli. 2005. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect. Control Hosp. Epidemiol.26:166-174.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-Free Systems: Ideal Platforms for Accelerating the Discovery and Production of Peptide-Based Antibiotics;International Journal of Molecular Sciences;2024-08-22

2. Dual release of daptomycin and BMP-2 from a composite of β-TCP ceramic and ADA gelatin;BMC Biotechnology;2024-06-03

3. Dual Release of Daptomycin and BMP-2 from a Composite of β-TCP Ceramic and ADA Gelatin for Bone Regeneration;2024-01-15

4. Evaluation of the Antibacterial Effect of Aurone-Derived Triazoles on Staphylococcus aureus;Antibiotics;2023-08-26

5. Highly efficient antimicrobial agents based on sulfur-enriched, hydrophilic molybdenum disulfide nano/microparticles and coatings functionalized with palladium nanoparticles;Journal of Colloid and Interface Science;2021-06